BCG immunotherapy inhibits cancer progression by promoting the M1 macrophage differentiation of THP-1 cells via the Rb/E2F1 pathway in cervical carcinoma

Bacillus Calmette-Guérin (BCG) immunotherapy increases macrophage polarization toward M1-type macrophages. In the present study, to identify the M1/M2 marker genes in the carcinogenesis and progression of cervical cancer, the microarray datasets GSE9750 and GSE7803 were downloaded from The Cancer Ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Limin, Shi, Wenjuan, Xiao, Xiao, Wu, Xuemei, Hu, Haiyan, Yuan, Shixin, Liu, Kai, Liu, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493057/
https://www.ncbi.nlm.nih.gov/pubmed/34581419
http://dx.doi.org/10.3892/or.2021.8196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493057/
https://www.ncbi.nlm.nih.gov/pubmed/34581419
http://dx.doi.org/10.3892/or.2021.8196

Ejemplares similares